Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (81)

« Back to Publications

Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection.

Hou MM. et al, (2025), Nat Commun, 16

Gonorrhoea: rising cases and antimicrobial resistance.

Davis P. et al, (2025), BMJ, 389

Acceptability of the gonorrhoea human challenge model to accelerate vaccine development in UK men.

Firth C. et al, (2025), Vaccine, 54

An experimental model of clinical immunity for human malaria

Hou MM. et al, (2025)

Mixed-methods study assessing the acceptability and feasibility of Human Challenge Studies for Disease X in Healthy UK Adults in a SARS-CoV-2 pandemic setting.

Emary KR. et al, (2025), BMJ Public Health, 3

Roles and responsibilities of participants, researchers, and the media in the communication of vaccine trials: Experience from the United Kingdom's first COVID-19 vaccine trial.

Patrick-Smith M. et al, (2024), Vaccine, 42

Preliminary evidence supporting use of UK consensus definitions for necrotising otitis externa

Takata J. et al, (2024), Clinical Infection in Practice, 24

The collective voice of early phase COVID-19 vaccine trial participants: Insights for improving confidence in novel vaccines.

Thomas TM. et al, (2023), Hum Vaccin Immunother, 19

Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults.

Silk SE. et al, (2023), Med, 4, 668 - 686.e7

Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection.

Hou MM. et al, (2023), Sci Transl Med, 15

Co-producing Human and Animal Experimental Subjects: Exploring the Views of UK COVID-19 Vaccine Trial Participants on Animal Testing.

Vanderslott S. et al, (2023), Sci Technol Human Values, 48, 909 - 937

Systematic review of the diagnosis and management of necrotising otitis externa: Highlighting the need for high-quality research.

Takata J. et al, (2023), Clin Otolaryngol, 48, 381 - 394

Superior antibody immunogenicity of a RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults

Silk SE. et al, (2023)

UK consensus definitions for necrotising otitis externa: a Delphi study.

Hodgson SH. et al, (2023), BMJ Open, 13

Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.

Odera DO. et al, (2023), Sci Transl Med, 15

Load More

1
2
3
4
5
6